Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2008

01-01-2008

Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals

Authors: Anurag Rathore, Animesh Chatterjee, P. Sivarama, Naohiko Yamamoto, Tapan N. Dhole

Published in: Journal of Clinical Immunology | Issue 1/2008

Login to get access

Abstract

Despite multiple sexual exposures to HIV-1 virus, some individuals remain HIV-1 seronegative. Although several genetic factors have been related to HIV-1 resistance, the homozygosity for a mutation in CCR5 gene (the 32-bp deletion, i.e., CCR5-Delta32 allele) is presently considered the most relevant one. The C-type lectins, DC-SIGN (present on dendritic cells and macrophages) and DC-SIGNR (present on endothelial cells in liver and lymph nodes) efficiently bind and transmit HIV-1 to susceptible cell in trans, thereby augmenting the infection. A potential association of the DC-SIGN and DC-SIGNR neck domain repeat polymorphism and risk of HIV-1 infection is currently under debate. To determine the influence of host genetic factors on HIV-1 resistance, we conducted genetic risk association study in HIV-1-exposed seronegative (n = 47) individuals, HIV-1 seronegative (n = 262) healthy control, and HIV-1-infected seropositive patients (n = 168) for polymorphism in neck domain of DC-SIGN and DC-SIGNR genes. The DC-SIGN and DC-SIGNR genotypes were identified by polymerase chain reaction method in DNA extracted from peripheral blood and confirmed by sequencing. Fisher exact or χ 2 test was used for static analysis. DC-SIGN genotype and allele distribution was fairly similar in HIV-1-exposed seronegative, HIV-1 seropositive, and HIV-1 seronegative control. There was no statistical significance in the differences in the distribution of DC-SIGN genotypes. A total of 13 genotypes were found in DC-SIGNR neck repeat region polymorphism. Among all the genotypes, only 5/5 homozygous showed significant reduced risk of HIV-1 infection in HIV-1-exposed seronegative individuals (p = 0.009). A unique genotype 8/5 heterozygous was also found in HIV-1 seropositive individual, which is not reported elsewhere.
Literature
2.
go back to reference Hogan CM, Hammer SM. Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics. Ann Intern Med 2001;134(10):978–96.PubMed Hogan CM, Hammer SM. Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics. Ann Intern Med 2001;134(10):978–96.PubMed
3.
go back to reference Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86(3):367–77.PubMedCrossRef Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86(3):367–77.PubMedCrossRef
4.
go back to reference Soilleux EJ, Barten R, Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 from a cluster on 19p13. J Immunol 2000;165:2937–42.PubMed Soilleux EJ, Barten R, Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 from a cluster on 19p13. J Immunol 2000;165:2937–42.PubMed
5.
go back to reference Feinberg H, GuoY, Mitchell DA, Drickamer K, Weis WI. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 2005;280:1327–35.PubMedCrossRef Feinberg H, GuoY, Mitchell DA, Drickamer K, Weis WI. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 2005;280:1327–35.PubMedCrossRef
6.
go back to reference Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100:587–9.PubMedCrossRef Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100:587–9.PubMedCrossRef
7.
go back to reference Barreiro LB, Patin E, Nyrolles O, Cann HM, Gicquel B, Quintana-Murci. The heritage of pathogen Pressure and Ancient Demography in the Human Innate Immunity CD 209/CD 209 L Region. Am J Hum Genet 2005;77:869–86.PubMedCrossRef Barreiro LB, Patin E, Nyrolles O, Cann HM, Gicquel B, Quintana-Murci. The heritage of pathogen Pressure and Ancient Demography in the Human Innate Immunity CD 209/CD 209 L Region. Am J Hum Genet 2005;77:869–86.PubMedCrossRef
8.
go back to reference Mitchell DA, Fadden, AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR: subunit organization and building to multivalent ligands. J Biol Chem 2001;276:28939–45.PubMedCrossRef Mitchell DA, Fadden, AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR: subunit organization and building to multivalent ligands. J Biol Chem 2001;276:28939–45.PubMedCrossRef
9.
go back to reference Feinberg H, Mitchell DA, Drickamer R, Weis WI. Structural basis for selective recognition of Oligosaccharide by DC-SIGNR. Science 2001;294:2163–6.PubMedCrossRef Feinberg H, Mitchell DA, Drickamer R, Weis WI. Structural basis for selective recognition of Oligosaccharide by DC-SIGNR. Science 2001;294:2163–6.PubMedCrossRef
10.
go back to reference Guo Y, Feinberg H, Electrophoresis C, Mitchell DA, Alvarez R, Blixt O, et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 2004;11:591–8.PubMedCrossRef Guo Y, Feinberg H, Electrophoresis C, Mitchell DA, Alvarez R, Blixt O, et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 2004;11:591–8.PubMedCrossRef
11.
go back to reference Soilleux EJ, Morris LS, Lee B, Pohlmann S, Trowsdale J, Doms RW, et al. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J Pathol 2001;195:586–92.PubMedCrossRef Soilleux EJ, Morris LS, Lee B, Pohlmann S, Trowsdale J, Doms RW, et al. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J Pathol 2001;195:586–92.PubMedCrossRef
12.
go back to reference Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 2002;76:6841–4.PubMedCrossRef Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 2002;76:6841–4.PubMedCrossRef
13.
go back to reference Bashirova AA, Geijtenbeek TB, Van Duijnhoven GC, Van Vliet SJ, Eilering JB, Martin MP, et al. A dendritic cell specific intracellular adhesion molecule 3 grabbing nonintegrin (DC-SIGN) related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 2001;193:671–8.PubMedCrossRef Bashirova AA, Geijtenbeek TB, Van Duijnhoven GC, Van Vliet SJ, Eilering JB, Martin MP, et al. A dendritic cell specific intracellular adhesion molecule 3 grabbing nonintegrin (DC-SIGN) related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 2001;193:671–8.PubMedCrossRef
14.
go back to reference Liu H, Hwangbo Y, Holte S, Lee J, Wang C, Kaupp N, et al. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecular-3-grabbing nonintegrin in seronegative individual repeatedly exposed to HIV-1. J Infect Dis 2004;190:1055–8.PubMedCrossRef Liu H, Hwangbo Y, Holte S, Lee J, Wang C, Kaupp N, et al. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecular-3-grabbing nonintegrin in seronegative individual repeatedly exposed to HIV-1. J Infect Dis 2004;190:1055–8.PubMedCrossRef
15.
go back to reference Liu H, Carrington M, Wang C, Holte S, Lee J, Greene B, et al. Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV susceptibility. J Infect Dis 2006;193:698–702.PubMedCrossRef Liu H, Carrington M, Wang C, Holte S, Lee J, Greene B, et al. Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV susceptibility. J Infect Dis 2006;193:698–702.PubMedCrossRef
16.
go back to reference Chan VSF, Chan KYK, Chen Y, Poon LLM, et al. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS Corona virus infection. Nat Genet 2006;38:38–46.PubMedCrossRef Chan VSF, Chan KYK, Chen Y, Poon LLM, et al. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS Corona virus infection. Nat Genet 2006;38:38–46.PubMedCrossRef
17.
go back to reference Lichterfeld M, Nischalke HD, van Lunzen J, et al. The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS. Clin Immunol 2003;107:55–9.PubMedCrossRef Lichterfeld M, Nischalke HD, van Lunzen J, et al. The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS. Clin Immunol 2003;107:55–9.PubMedCrossRef
18.
go back to reference Pohlmann S, Zhang J, Baribaud F, Chen Z, et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003;77:4070–80.PubMedCrossRef Pohlmann S, Zhang J, Baribaud F, Chen Z, et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003;77:4070–80.PubMedCrossRef
19.
go back to reference Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, et al. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003;305:115–23.PubMedCrossRef Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, et al. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003;305:115–23.PubMedCrossRef
20.
go back to reference Gramberg T, Zhu T, Chaipan C, et al. Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens. Virology 2006;347:354–63.PubMedCrossRef Gramberg T, Zhu T, Chaipan C, et al. Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens. Virology 2006;347:354–63.PubMedCrossRef
21.
go back to reference Feinberg H, CAstelli R, Drickmer K, Seeberger PH, Weis WI. Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins. J Biol Chem 2006;286(6):4202–9.CrossRef Feinberg H, CAstelli R, Drickmer K, Seeberger PH, Weis WI. Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins. J Biol Chem 2006;286(6):4202–9.CrossRef
22.
go back to reference Snyder GA, Ford J, Torabi-Parizi P, et al. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor’s role as an antigen-capturing rather than an adhesion receptor. J Virol 2005;79:4589–98.PubMedCrossRef Snyder GA, Ford J, Torabi-Parizi P, et al. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor’s role as an antigen-capturing rather than an adhesion receptor. J Virol 2005;79:4589–98.PubMedCrossRef
23.
go back to reference Guo Y, Atkinson CE, Taylor ME, Drickmer K. All but the shortest polymorphic forms of the viral receptor DC-SIGNR assemble into homo- and heterotetramers. J Biol Chem 2006;281:16794–8.PubMedCrossRef Guo Y, Atkinson CE, Taylor ME, Drickmer K. All but the shortest polymorphic forms of the viral receptor DC-SIGNR assemble into homo- and heterotetramers. J Biol Chem 2006;281:16794–8.PubMedCrossRef
24.
go back to reference Wichukchinda N, Kitamura Y, Rojanawiwat A, Nakayama EE, Song H, et al. The polymorphism in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retrovir 2007;23:686–92.PubMedCrossRef Wichukchinda N, Kitamura Y, Rojanawiwat A, Nakayama EE, Song H, et al. The polymorphism in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retrovir 2007;23:686–92.PubMedCrossRef
Metadata
Title
Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals
Authors
Anurag Rathore
Animesh Chatterjee
P. Sivarama
Naohiko Yamamoto
Tapan N. Dhole
Publication date
01-01-2008
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2008
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-007-9131-x

Other articles of this Issue 1/2008

Journal of Clinical Immunology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.